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Abstract 
Purpose: To show the evolution of anterior chamber structures 6 years after cataract surgery 
in a case with Acanthamoeba keratitis (AK).  
Methods: A 37-year-old woman with AK receiving long-term treatment with chlorhexidine, 
propamidine isethionate and steroids developed a white cataract and iris atrophy. 
Penetrating keratoplasty and cataract surgery were performed with subsequent intraocular 
pressure elevation requiring Molteno shunt implantation. Two years after the last surgery, 
endothelial decompensation developed and another penetrating keratoplasty was 
performed. Intraoperatively, the anterior and posterior capsules were completely 
transparent.  
Results: Six years after cataract surgery, the intraocular lens was centered with clear anterior 
and posterior capsules without lens epithelial cells proliferation. No Soemmering’s ring 
formation or posterior capsule opacification was found. Also, no zonular damage or 
pseudophacodonesis was observed.  
Conclusions: This case suggests that AK infection and AK treatment not only cause white 
progressive cataract but also lens epithelial cell death. The capsules may be completely clear 
6 years after cataract surgery, with a good quality of vision regardless of intraocular lens 
material or design. 
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Introduction 
Acanthamoeba keratitis (AK) is often misdiagnosed initially because of specific 
clinical signs in the early stage that mimic other types of corneal infection. Claerhout et 
al. [1] suggested that a diagnostic delay of more than 18 days between symptom onset 
and the start of antiamoebic treatment results in poor final visual acuity (VA). Recently, 
Chew et al. [2] found that after AK, 24% of patients rapidly developed mature cataracts 
and 6% suffered from iris atrophy. In addition, different reports on the toxicity of AK 
treatments have been published [1, 3]. For example, Ehlers and Hjortdal [3] reported 2 
cases with a white cataract, secondary glaucoma, and iris atrophy after prolonged 
treatment with 0.02% chlorhexidine and 0.1% propamidine isethionate. Cataract, iris 
atrophy, and ischemic ocular inflammation are associated with chlorhexidine use [3, 4] 
or topical polyhexamethylene biguanide 0.02% [2] in patients with AK. Cationic 
compounds such as chlorhexidine can disrupt the lens surface, provoke lenticular 
oxidative or osmotic stress, and contribute to cataract formation by altering lipid 
membranes, damaging lens fibers, and inducing electrolyte imbalances [5]. Chew et al. 
[2] suggested that the presence of chlorhexidine or polyhexamethylene biguanide 
combined with the reactive inflammation in patients with severe stromal disease led to 
the decompensation of the lens capsule and subsequent rapid progression of mature 
cataracts. 
We describe a patient with AK and adverse effects such as white cataract, glaucoma, 
and iris atrophy. The patient underwent phacoemulsification and intraocular lens (IOL) 
implantation, glaucoma drainage implant surgery, and penetrating keratoplasty (PKP). 
After 6 years of follow-up, no capsular opacification or zonular damage was observed, 
and the lens epithelial cells (LECs) were apparently destroyed. To our knowledge, no 
previous similar cases have been published. 
Case Report 
A 37-year-old woman with –6.0 diopters of myopia in the right eye wore a hydrogel contact lens. 
In August 2004, she reported intense ocular pain with punctate keratitis. The patient visited several 
doctors and finally, 2 months later, AK was diagnosed using confocal microscopy. Subsequently, a 
treatment with 0.02% chlorhexidine drops (three times/day), propamidine isethionate (Brolene; 
Rhône-Poulenc Rorer, Eastbourne, UK) (three times/day), and 0.25% fluorometholone drops (FML-
Forte; Allergan, Irvine, Calif., USA) (twice/day) was started in October 2004. 
In June 2005, the patient was referred to our department for PKP. The patient continued the 
treatment, and a white cataract, conjunctival hyperemia, corneal abscess, and iris atrophy developed 
(fig. 1). The best-corrected VA (BCVA) was light perception (3 logMar units) and the intraocular 
pressure (IOP) measured by pneumotonometry was 23 mm Hg. In July 2005, uneventful combined 
PKP and open sky cataract extraction was performed. A +14-diopter CZ-70-BD rigid IOL (Alcon 
Laboratories Inc., Fort Worth, Tex., USA) was implanted in the bag. The BCVA 3 months 
postoperatively was 0.2 logMar (+1.5–5 × 60°). The fundus was normal with a papilar cup/disc ratio 
of 0.6. However, the IOP was 25 mm Hg using timolol maleate and 0.15% brimonidine tartrate 
(Combigan; Allergan, Irvine, Calif., USA) (twice/day). Four months after PKP and cataract surgery, a 
double-plate Molteno shunt (Molteno Ophthalmic Ltd., Dunedin, New Zealand) was implanted in the 
superior quadrants, with the tube introduced into the nasal anterior chamber. 
In July 2007, the IOP was 16 mm Hg, but corneal stromal edema with endothelial decompensation 
developed and a second PKP was performed. A 7-mm-diameter PKP combined with posterior pars 
plana vitrectomy using a temporary keratoprosthesis was performed. The Molteno implant tube was 
moved from the anterior chamber to the vitreous cavity in order to increase the distance between the  
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Molteno tube and the corneal button, thereby avoiding endothelial decompensation. During surgery, 
the anterior and posterior capsules were transparent, with no LEC proliferation or adherence of the 
capsules (fig. 2). The IOL was moved inside the capsular bag after the corneal button was removed, 
and no adherence between the capsules and IOL was observed. In July 2009, the BCVA was 0.05 
logMar (+1.5–2.5 × 110°) and the corneal graft was clear (1,500 endothelial cells/mm2). The IOP was 
17 mm Hg using 0.5% timolol maleate (twice/day) and fluorometholone (three times/day). The IOL 
was centered with clear anterior and posterior capsules without LEC proliferation (fig. 3). The IOL 
edge was clear; there was no zonular damage or pseudophacodonesis. The patient wore a brown 
cosmetic contact lens to treat the photophobia with a similar iris color to that of the left eye. 
Results and Discussion 
The current case demonstrates the effects of AK infection and AK treatment on the 
anterior chamber structures after cataract surgery with a follow-up of 6 years. The 
clear PKP and the iris atrophy facilitate observation of the IOL, capsular bag, and the 
zonular fibers. Ehlers and Hjortdal [3] described 2 almost identical cases with similar 
characteristics, but with a follow-up of 6 months. No effects of AK infection and AK 
treatment on the LECs have been described. The intention of this report is to point out 
the apparent death of LECs without posterior capsule opacification (PCO) after 6 years 
of follow-up in a case with severe AK. 
The apparent LEC death in the current case was associated with remarkable 
characteristics. First, both capsules were totally clear without adhesion between them, 
which could be important for evaluating the retinal periphery if needed. Second, the 
IOL haptics did not adhere to the capsules 2 years after cataract surgery (during the 
second PKP), and the IOL was moved inside the capsular bag without resistance, 
suggesting the possibility of an easy IOL exchange in late postoperative stages. In 
addition, the IOL was inside and centered in the capsular bag because the 
capsulorrhexis diameter was smaller than the diameter of the IOL optic. These factors 
indicate that the adhesion of the capsules to each other or between the capsules and the 
IOL may be unnecessary for centering the IOL and maintaining the IOL inside the bag. 
Although the IOL was large, no folds or wrinkles developed in the posterior capsule 
because no posterior capsule fibrosis had developed – an important factor in the 
quality of vision. No Soemmering’s ring formation outside the IOL optic was found. No 
PCO was observed with this rounded-edge optic IOL, suggesting that the LEC 
destruction was the most important prevention factor in this case. Finally, no zonular 
damage or pseudophacodonesis was observed; thus, no apparent modification of the 
zonular fibers occurred in this case. 
Indirectly, this case also showed that LEC death may completely prevent PCO. PCO 
remains the most frequent long-term complication of cataract surgery, with high rates 
in young adults and children [6]. PCO is caused by collagen deposition, proliferation 
and migration of residual LECs, epithelial-mesenchymal transition, and lens fiber 
generation [6]. This case also showed that completely clear capsules are possible 6 
years after cataract surgery, with a good quality of vision independent of IOL material 
or designs. Selective LEC death resulting from administration of cytotoxic 
pharmacologic agents without endothelial or iris damage is not presently possible, 
except with the use of devices for protecting other tissues in the anterior chamber. 
Maloof et al. [7] reported on the Perfect Capsule device (Milvella Ltd., Sydney, N.S.W., 
Australia) that permits delivery of cytotoxic agents selectively into the capsular bag.  
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Awasthi et al. [6] suggested that targeting residual LECs with therapeutic agents that 
have minimal or no effect on other ocular tissues is a highly desirable approach for 
eradicating PCO. 
The current case suggests that rapid and progressive mature cataract formation in 
AK may be related to LEC destruction and PCO prevention 6 years after cataract 
surgery. 
Disclosure Statement 
None of the authors has a financial, commercial, or proprietary interest in any instrument or 
intraocular lens mentioned in this report. 
 
 
 
 
 
 
Fig. 1. White cataract, conjunctival hyperemia, corneal abscess, and iris atrophy (arrows) secondary 
to AK. 
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Fig. 2. Clear capsules observed during vitrectomy using a Landis temporary keratoprosthesis. This 
procedure was performed 2 years after cataract surgery with IOL implantation. 
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Fig. 3. Haptic and optic (white arrows) of the CZ-70-BD rigid IOL. No LEC proliferation is observed. 
The capsules are clear 6 years after cataract surgery. Note the absence of Soemmering’s ring 
formation outside the IOL optic. 
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